BRIEF-Aeterna and Rafa Laboratories sign license agreement for Zoptrex in Israel

* Aeterna Zentaris and Rafa Laboratories sign exclusive

license agreement for Zoptrex in Israel

Read more

BRIEF-Eyegate Pharmaceuticals reports positive top-line data

* Eyegate announces positive top-line data from phase 1B/2A

clinical trial of EGP-437 for treatment of post-operative

inflammation and pain in cataract surgery patients

Source text for Eikon:

Further company coverage:

Read more

Keryx withdraws 2016 forecast on renal drug supply interruption

Aug 1 (Reuters) - Keryx Biopharmaceuticals Inc said

it was withdrawing its full-year forecast due to issues related

to the production of its only approved drug, Auryxia.

Read more

Investor Wyser-Pratte calls for sale of Stada to CVC

FRANKFURT, Aug 1 (Reuters) - U.S. activist investor Guy

Wyser-Pratte, who has acquired a stake in Stada, said

the German maker of generic drugs and consumer care products

should soon be sold to buyout firm CVC Capital Partners

.

Read more

BRIEF-Vical announces $7.8 mln equity investment by partner Anges MG

* Vical announces $7.8 million equity investment by partner,

Anges MG

Read more

BRIEF-Haemonetics Corp Q1 adjusted earnings per share $0.25

* Q1 fiscal 2017 revenue of $210.0 million; Q1 earnings per

share $0.20; Q1 adjusted earnings per share $0.25

Read more

BRIEF-Jiangsu Bicon Pharmaceutical Listed enters into cooperation memorandum with Cisco Systems International, B.V.

* Says the co entered into cooperation memorandum with Cisco

Systems International, B.V.

Read more